BioAdaptives®, Inc. (OTC BB: BDPT) complete regulatory filings are available on Edgar
FORM 10-Q AMENDMENT NO. 1 June 11 2020
Form PRE 14C February 10, 2020
Form 10-Q ending June 30, 2019.
10-Q Quarter Ending September 30, 2016
10-Q Quarter Ending Jun 30, 2016
10-Q Quarter Ending March 31, 2016
10-Q Quarter Ending September 30, 2015
10-Q Quarter Ending June 30, 2015
10-Q Quarter Ending March 31, 2015
3rd Quarter 10-Q (Quarter ended September 30, 2013)
2nd Quarter 10-Q (Quarter ended June 30, 2013)
https://www.otcmarkets.com/stock/BDPT/disclosure
Quarterly Report for Period ending: March 31, 2019.
Annual Report For the Period Ending: December 31st. 2018
10-Q Quarter Ending September 30, 2018
10-Q Quarter Ending June 30, 2018
10-Q Quarter ending March 31, 2018
10-K Annual Report December 31, 2017
10-Q Quarter Ending September 30, 2017
10-Q Quarter Ending Jun 30, 2017
10-Q Quarter Ending March 31, 2017
10-k Annual Report December 31, 2016
Statements on this website and of the management or representatives of BioAdaptives Inc. (the “Company”) in connection therewith that relate to beliefs, plans, objectives, goals, expectations, anticipations, intentions and future financial condition, results of operations or business performance constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on management’s current expectations about future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts, and by words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “project,” “anticipate,” “estimate,” “intend,” “plan” or other similar words or expressions.
Any or all of the forward-looking statements on this website or made by management may turn out to be in accurate or wrong. This can occur as a result of inaccurate assumptions or as a consequence of significant known or unknown risks and uncertainties. The Company addresses these risks in the “Risk Factors” section of its filings with the SEC. Because of these risks and uncertainties, the Company’s actual results may differ materially from those that might be anticipated from its forward-looking statements. Therefore, you are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Also, in presenting this material and responding to inquiries in connection to future performance of the company, management may refer to results, projections, or performance measures that are not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) as reported in the company’s SEC filings. You are advised that these results, projections, or performance measures are non-GAAP measures and are not intended to replace or as a substitute for results measured under GAAP but rather as a supplement to the GAAP reported results.
This website or alerts from our website do not constitute or form part of an offer to sell or issue or invitation to purchase or subscribe for any shares of the Company in any jurisdiction, and no part of this website shall form the basis of or be relied upon in connection with any contract or commitment. Specifically, this website with corporate overview does not constitute a “prospectus” within the meaning of the U.S. Securities Act of 1933, as amen
English
EspañolEnglish